Moreover, although shRNA-mediated loss of LATS1 did not affect primary tumor growth of HCC cells in xenotransplanted immunodeficient mice, it significantly reduced tumor growth under Srf treatment (Fig. 1c and Supplementary Fig. 1f). Here, LATS1 is linked to neoplasm.